Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical hydrocortisone versus paraffin gauze for small non-healing post-burn skin graft loss wounds
ACTRN12617001058369Phase 4Completed
- Sponsor
- Farrukh Aslam Khalid
- Start
- Jul 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fusidic acid and chlorhexidine in burn injury (2 arms), sponsored by Farrukh Aslam Khalid. Primary endpoints: Time to re-epithelialization and Granulation tissue formation and re-epithelialization assessment. Started Jul 2017; status: completed.
02
Drugs
fusidic acidchlorhexidine
03
Conditions
burn injury
Beyond the preview
Go deeper on ACTRN12617001058369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001058369.